Paclitaxel drug-coated balloon angioplasty for the treatment of failing arteriovenous fistulas: a single-center experience

References

• Vascular Access Work Group. Clinical practice guidelines for vascular access. Am J Kidney Dis 2006;48:S176–S247.
   PubMedGoogle Scholar
• Ohira S, Naito H, Amano I, et al. 2005 Japanese Society for Dialysis Therapy guidelines for vascular access construction and repair for chronic hemodialysis. 2006;10:449–462.
   Google Scholar
• Jindal K, Chan CT, Deziel C, et al. Hemodialysis clinical practice guidelines for the Canadian Society of Nephrology. J Am Soc Nephrol. 2006;17:S1–S27.
   PubMed Web of Science ®Google Scholar
• Tordoir J, Canaud B, Haage P, et al. EBPG on vascular access. Nephrol Dial Transplant. 2007;22:ii88–i117.
   PubMed Web of Science ®Google Scholar
• Riella MC, Roy-Chaudhury P. Vascular access in haemodialysis: strengthening the Achilles' heel. Nat Rev Nephrol. 2013;9:348–357.
   PubMed Web of Science ®Google Scholar
• Campos RP, Do Nascimento MM, Chula DC, et al. Stenosis in hemodialysis arteriovenous fistula: evaluation and treatment. Hemodial Int. 2006;10:152–161.
   PubMedGoogle Scholar
• Trerotola SO, Kwak A, Clark TW, et al. Prospective study of balloon inflation pressures and other technical aspects of hemodialysis access angioplasty. J Vasc Interv Radiol: JVIR. 2005;16:1613–1618.
   PubMed Web of Science ®Google Scholar
• Saleh HM, Gabr AK, Tawfik MM, et al. Prospective, randomized study of cutting balloon angioplasty versus conventional balloon angioplasty for the treatment of hemodialysis access stenoses. J Vasc Surg. 2014;60:735–740.
   PubMed Web of Science ®Google Scholar
• Aftab SA, Tay KH, Irani FG, et al. Randomized clinical trial of cutting balloon angioplasty versus high-pressure balloon angioplasty in hemodialysis arteriovenous fistula stenoses resistant to conventional balloon angioplasty. J Vasc Interv Radiol: JVIR. 2014;25:190–198.
   PubMed Web of Science ®Google Scholar
• Kufner S, Cassese S, Valeskini M, et al. Long-term efficacy and safety of paclitaxel-eluting balloon for the treatment of drug-eluting stent restenosis: 3-year results of a randomized controlled trial. JACC: Cardiovasc Interv. 2015;8:877–884.
   PubMed Web of Science ®Google Scholar
• Stone GW, Moses JW, Ellis SG, et al. Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents. N Engl J Med. 2007;356:998–1008.
   PubMed Web of Science ®Google Scholar
• Siontis GCM, Stefanini GG, Mavridis D, et al. Percutaneous coronary interventional strategies for treatment of in-stent restenosis: a network meta-analysis. Lancet. 2015;386:655–664.
   PubMed Web of Science ®Google Scholar
• Tepe G, Zeller T, Albrecht T, et al. Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg. N Engl J Med. 2008;358:689–699.
   PubMed Web of Science ®Google Scholar
• Cassese S, Byrne RA, Ott I, et al. Paclitaxel-coated versus uncoated balloon angioplasty reduces target lesion revascularization in patients with femoropopliteal arterial disease: a meta-analysis of randomized trials. Circ Cardiovasc Interv. 2012;5:582–589.
   PubMed Web of Science ®Google Scholar
• Colleran R, Harada Y, Cassese S, et al. Drug coated balloon angioplasty in the treatment of peripheral artery disease. Expert Rev Med Devices. 2016;13:569–582.
   PubMed Web of Science ®Google Scholar
• Baerlocher MO, Kennedy SA, Rajebi MR, et al. Meta-analysis of drug-eluting balloon angioplasty and drug-eluting stent placement for infrainguinal peripheral arterial disease. J Vasc Interv Radiol: JVIR. 2015;26:459–473 e4.
   PubMed Web of Science ®Google Scholar
• Katsanos K, Karnabatidis D, Kitrou P, et al. Paclitaxel-coated balloon angioplasty vs. plain balloon dilation for the treatment of failing dialysis access: 6-month interim results from a prospective randomized controlled trial. J Endovasc Ther: Off J Int Soc Endovasc Specialists. 2012;19:263–272.
   PubMed Web of Science ®Google Scholar
• Kitrou PM, Spiliopoulos S, Katsanos K, et al. Paclitaxel-coated versus plain balloon angioplasty for dysfunctional arteriovenous fistulae: one-year results of a prospective randomized controlled trial. J Vasc Interv Radiol. 2015;26:348–354.
   PubMed Web of Science ®Google Scholar
• Kitrou PM, Spiliopoulos S, Papadimatos P, et al. Paclitaxel-coated balloons for the treatment of dysfunctional dialysis access. Results from a single-center, retrospective analysis. Cardiovasc Interv Radiol. 2016;40:50–54.
   PubMed Web of Science ®Google Scholar
• Lai C-C, Fang H-C, Tseng C-J, et al. Percutaneous angioplasty using a paclitaxel-coated balloon improves target lesion restenosis on inflow lesions of autogenous radiocephalic fistulas: a pilot study. J Vasc Interv Radiol. 2014;25:535–541.
   PubMed Web of Science ®Google Scholar
• Patane D, Giuffrida S, Morale W, et al. Drug-eluting balloon for the treatment of failing hemodialytic radiocephalic arteriovenous fistulas: our experience in the treatment of juxta-anastomotic stenoses. J Vasc Access. 2014;15:338–343.
   PubMed Web of Science ®Google Scholar
• Massmann A, Fries P, Obst-Gleditsch K, et al. Paclitaxel-coated balloon angioplasty for symptomatic central vein restenosis in patients with hemodialysis fistulas. J Endovasc Ther. 2015;22:74–79.
   PubMed Web of Science ®Google Scholar
• Swinnen JJ, Zahid A, Burgess DC. Paclitaxel drug-eluting balloons to recurrent in-stent stenoses in autogenous dialysis fistulas: a retrospective study. J Vasc Access. 2015;16:388–393.
   PubMed Web of Science ®Google Scholar
• Cildag MB, Koseoglu OF, Akdam H, et al. The primary patency of drug-eluting balloon versus conventional balloon angioplasty in hemodialysis patients with arteriovenous fistula stenoses. Jpn J Radiol. 2016;34:700–704.
   PubMed Web of Science ®Google Scholar
• Ierardi AM, Franchin M, Fontana F, et al. Usefulness of paclitaxel-releasing high-pressure balloon associated with cutting balloon angioplasty for treatment of outflow stenoses of failing hemodialysis arteriovenous shunts. Radiol Med. 2017;122:69–76.
   PubMed Web of Science ®Google Scholar
• Kitrou PM, Katsanos K, Spiliopoulos S, et al. Drug-eluting versus plain balloon angioplasty for the treatment of failing dialysis access: final results and cost-effectiveness analysis from a prospective randomized controlled trial (NCT01174472). Eur J Radiol. 2015;84:418–423.
   PubMed Web of Science ®Google Scholar
• Khawaja AZ, Cassidy DB, Al Shakarchi J, et al. Systematic review of drug eluting balloon angioplasty for arteriovenous haemodialysis access stenosis. J Vasc Access. 2016;17:103–110.
   PubMed Web of Science ®Google Scholar
• Boitet A, Massy ZA, Goeau-Brissonniere O, et al. Drug coated balloon angioplasty for dialysis access fistula stenosis. Semin Vasc Surg. 2016;29:178–185.
   PubMed Web of Science ®Google Scholar
• Vascular BP. Lutonix® 035 Drug Coated Balloon PTA Catheter 5F 2016. 2017. Available from: http://www.bardpv.com/portfolio/lutonix-035/.
   Google Scholar
• Oberhoff M, Herdeg C, Al Ghobainy R, et al. Local delivery of paclitaxel using the double-balloon perfusion catheter before stenting in the porcine coronary artery. Catheter Cardiovasc Interv. 2001;53:562–568.
   PubMed Web of Science ®Google Scholar
• Oberhoff M, Kunert W, Herdeg C, et al. Inhibition of smooth muscle cell proliferation after local drug delivery of the antimitotic drug paclitaxel using a porous balloon catheter. Basic Res Cardiol. 2001;96:275–282.
   PubMed Web of Science ®Google Scholar
• Axel DI, Kunert W, Goggelmann C, et al. Paclitaxel inhibits arterial smooth muscle cell proliferation and migration in vitro and in vivo using local drug delivery. Circulation. 1997;96:636–645.
   PubMed Web of Science ®Google Scholar
• Allon M, Litovsky S, Young CJ, et al. Medial fibrosis, vascular calcification, intimal hyperplasia, and arteriovenous fistula maturation. Am J Kidney Dis. 2011;58:437–443.
   PubMed Web of Science ®Google Scholar
• Roy-Chaudhury P, Arend L, Zhang J, et al. Neointimal hyperplasia in early arteriovenous fistula failure. Am J Kidney Dis. 2007;50:782–790.
   PubMed Web of Science ®Google Scholar
• Roy-Chaudhury P, Wang Y, Krishnamoorthy M, et al. Cellular phenotypes in human stenotic lesions from haemodialysis vascular access. Nephrol Dial Transplant. 2009;24:2786–2791.
   PubMed Web of Science ®Google Scholar
• Maleux G, Vander Mijnsbrugge W, Henroteaux D, et al. Multicenter, randomized trial of conventional balloon angioplasty versus paclitaxel-coated balloon angioplasty for the treatment of dysfunctioning autologous dialysis fistulae. J Vasc Interv Radiol. 2018;29:470–475.
   PubMed Web of Science ®Google Scholar
• Kitrou P, Spiliopoulos S, Karnabatidis D, et al. Cutting balloons, covered stents and paclitaxel-coated balloons for the treatment of dysfunctional dialysis access. Expert Rev Med Devices. 2016;13:1119–1126.
   PubMed Web of Science ®Google Scholar
• Karunanithy N, Mesa IR, Dorling A, et al. Paclitaxel-coated balloon fistuloplasty versus plain balloon fistuloplasty only to preserve the patency of arteriovenous fistulae used for haemodialysis (PAVE): study protocol for a randomised controlled trial. Trials. 2016;17:241.
   PubMed Web of Science ®Google Scholar
• US National Library of Medicine. Primary Patency in Post-angioplasty Dysfunctional Arteriovenous Fistula in Renal Dialysis: Paclitaxel-releasing PTA Balloon Catheter vs PTA Balloon (FISBAL). December 2017. Available from: https://clinicaltrials.gov/ct2/show/NCT02565953?term=%28FISBAL%29.&rank=1.
   Google Scholar
• US National Library of Medicine. Prospective Randomized Trial Comparing DEB Versus Conventional PTA for the Treatment of Hemodialysis AVF or AVG Stenoses (DEBAPTA). December 2017. Available from: https://clinicaltrials.gov/ct2/show/NCT01544907.
   Google Scholar
• US National Library of Medicine. RCT of Paclitaxel DEB Compared to Standard PTA in Dialysis Fistula (APERTO). December 2017. Available from: https://clinicaltrials.gov/ct2/show/NCT02558153.
   Google Scholar
• US National Library of Medicine. Study Comparing Lutonix AV Drug Coated Balloon vs Standard Balloon for Treatment of Dysfunctional AV Fistulae. December 2017. Available from: https://clinicaltrials.gov/ct2/show/NCT02440022.
   Google Scholar
• Hill NR, Fatoba ST, Oke JL, et al. Global prevalence of chronic kidney disease – a systematic review and meta-analysis. PLoS One. 2016;11:e0158765.
   PubMed Web of Science ®Google Scholar